Stage IIIC Prostate Cancer AJCC v8

specific

Stage IIIC includes: Any T, N0, M0, PSA: Any, Grade Group 5. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 5: Gleason Score 9 or 10, Gleason Pattern 4+5, or 5+4, or 5+5. (AJCC 8th ed.)

Centers

Active Trials

—

Cancer Funding

Top Centers for Stage IIIC Prostate Cancer AJCC v8(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Winship Cancer InstituteAtlanta, GA NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	72.7
2	University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	—	72.7
3	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	63.8
4	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	1	—	63.8
5	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	63.8
6	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	63.8
7	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	63.8
8	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	1	—	63.8
9	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	63.8
10	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	63.8
11	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	63.8
12	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	63.8
13	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	1	—	63.8
14	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		—	—	42.7
15	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive		—	—	42.7
16	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive		—	—	42.7
17	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive		—	—	42.7
18	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive		—	—	42.7
19	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive		—	—	42.7
20	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive		—	—	42.7
21	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive		—	—	42.7
22	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive		—	—	42.7
23	Medical College of Wisconsin Cancer CenterMilwaukee, WI		—	—	42.7
24	Cedars-Sinai CancerLos Angeles, CA		—	—	42.7
25	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive		—	—	42.7
26	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive		—	—	42.7
27	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		—	—	42.7
28	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical		—	—	42.7
29	Boston University Cancer CenterBoston, MA		—	—	42.7
30	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive		—	—	42.7
31	Stony Brook Cancer CenterStony Brook, NY		—	—	42.7
32	Penn State Cancer InstituteHershey, PA		—	—	42.7
33	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR		—	—	42.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →